Literature DB >> 9596549

NSAID induced gastrointestinal complications: the ARAMIS perspective--1997. Arthritis, Rheumatism, and Aging Medical Information System.

G Singh1, D Rosen Ramey.   

Abstract

Gastrointestinal (GI) complications related to nonsteroidal antiinflammatory drug (NSAID) therapy are the most prevalent category of adverse drug reactions. Patients with arthritis are among the most frequent users of NSAID and are therefore particularly at risk for these side effects. To evaluate the nature of NSAID related GI complications and to determine how their frequency can be reduced, a series of studies of such complications in patients with rheumatic disease has been carried out based on data from the Arthritis, Rheumatism, and Aging Medical Information System (ARAMIS). We review the literature and present findings from the ARAMIS studies. This report addresses whether GI side effects such as dyspepsia can serve as warning symptoms for serious GI complications and describes the risk factors for these life threatening complications. It also describes differences among NSAID with regard to their GI toxicity and describes a study that investigated whether H2-receptor antagonists and antacids affect the development of serious GI complications. In addition, ongoing research and topics to be addressed in future studies are described.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596549

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  73 in total

Review 1.  Spondylarthropathies: options for combination therapy.

Authors:  A M van Tubergen; R B Landewé; S van der Linden
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Photosensitivity to ketoprofen: mechanisms and pharmacoepidemiological data.

Authors:  H Bagheri; V Lhiaubet; J L Montastruc; N Chouini-Lalanne
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

3.  Preventing NSAID Toxicity to the Upper Gastrointestinal Tract.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

Review 4.  [Therapy with nonsteroidal anti-inflammatory drugs].

Authors:  H Bauer; E Märker-Hermann
Journal:  Orthopade       Date:  2003-12       Impact factor: 1.087

5.  Non-surgical treatment of osteoarthritis: a half century of "advances".

Authors:  K D Brandt
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

6.  Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials.

Authors:  Jinying Lin; Weiya Zhang; Adrian Jones; Michael Doherty
Journal:  BMJ       Date:  2004-07-30

7.  Factors that influence prescribers in their selection and use of COX-2 selective inhibitors as opposed to non-selective NSAIDs.

Authors:  Anna I Gunnarsdóttir; Moira Kinnear
Journal:  Pharm World Sci       Date:  2005-08

Review 8.  Nitric oxide-releasing NSAIDs: a review of their current status.

Authors:  S Fiorucci; E Antonelli; J L Burgaud; A Morelli
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

9.  NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies.

Authors:  Alberto Pilotto; Marilisa Franceschi; Gioacchino Leandro; Francesco Di Mario
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.

Authors:  Andrew Moore; Ceri Phillips; Elke Hunsche; James Pellissier; Simone Crespi
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.